CMV Colitis: A Rare Complication of Azacitidine and Venetoclax Chemotherapy.
Mustafa Nissar BankurArchie KeelingKhoodoruth Mohamed Adil ShahDaniele AvenosoPublished in: Hematology reports (2022)
Herein, we present a case of cytomegalovirus (CMV) colitis that occurred after two cycles of azacitidine and venetoclax in a 64-year-old woman affected with acute myeloid leukaemia (AML) secondary to a previous diagnosis of a hypoplastic myelodysplastic syndrome (hypo-MDS). This patient never had detectable CMV viraemia, and there was no evidence of immune deficiency that could justify this opportunistic infection. Additionally, this is most likely the first report describing CMV colitis in a patient treated upfront with azacitidine and venetoclax.
Keyphrases
- acute myeloid leukemia
- chronic lymphocytic leukemia
- case report
- allogeneic hematopoietic stem cell transplantation
- ulcerative colitis
- liver failure
- squamous cell carcinoma
- epstein barr virus
- drug induced
- locally advanced
- intensive care unit
- acute lymphoblastic leukemia
- immune response
- extracorporeal membrane oxygenation